Helen Liang
InvestorFounderFounder / Managing Partner at FoundersX Ventures · Board director at Cognito Therapeutics Group · Founder & Managing Partner at FS2 · Board director at Cognito Therapeutics
Silicon Valley
FoundedFS2
Find your path to Helen
5,351 people in our graph share verified history with Helen — schools, employers, funds. One of them is your warm intro.
About
Helen Liang founded FoundersX Ventures in 2016 with backing from a founders circle connected to Stanford, and brings more than 10 years of product experience in high-tech industries. She leads the firm's investing in enterprise AI, fintech, digital health, and biotech. She holds a PhD from the University of Wisconsin-Madison, completed the Harvard HBS PE/VC program (Class of 2022), and is a guest lecturer at Stanford.
Invests in
AI & Machine LearningBiotechDigital HealthEnterprise SoftwareFintech
Board director at Cognito Therapeutics Group
Intro paths
In turn, Helen can intro founders to Cognito Therapeutics Group's investors below.
Cognito Therapeutics Group's investors · 1
Founder & Managing Partner at FS2
Intro paths
In turn, Helen can intro founders to FS2's investors below.
FS2's investors · 1
Board director at Cognito Therapeutics
Intro paths
In turn, Helen can intro founders to Cognito Therapeutics's investors below.
Cognito Therapeutics's investors · 1
Experience
- FoundersX VenturesFounder & Managing Partnercurrent2016 — presentMenlo Park
- World LabsInvestorcurrent2026 — presentSan Francisco Bay Area
- SpaceXInvestorcurrent2020 — presentLos Angeles, California, United States
- Turion SpaceInvestorcurrent2021 — presentLos Angeles Metropolitan Area
- Universal QuantumInvestorcurrent2020 — presentGreater London, England, United Kingdom
- Solve IntelligenceInvestorcurrent2023 — presentSan Francisco Bay Area
- FS2Investor & Board Directorcurrent2025 — presentBoston, Massachusetts, United States
- Linvest21Investor & Board Directorcurrent2023 — presentNew York City Metropolitan Area
- KapitalInvestorcurrent2022 — presentMexico
- Alinea InvestInvestorcurrent2024 — presentNew York City Metropolitan Area
- JeevesInvestorcurrent2020 — presentManhattan, New York, United States
- Salt SecurityInvestorcurrent2016 — presentSan Francisco Bay Area
- Charge RoboticsInvestorcurrent2022 — presentSan Francisco Bay Area
- Mbodi AIInvestorcurrent2025 — presentSan Francisco Bay Area
- DreamFlare AIInvestor & Board Directorcurrent2023 — presentLondon Area, United Kingdom
- Markable AIInvestor & Board Directorcurrent2021 — presentSan Francisco Bay Area
- NitraInvestorcurrent2022 — presentNew York City Metropolitan Area
- Glyphic BiotechnologiesInvestorcurrent2024 — presentSan Francisco Bay Area
- Cognito Therapeutics, Inc.Investor and Board Observercurrent2022 — presentSan Francisco Bay Area
- OmniscopeInvestor & Board Advisorcurrent2023 — presentSan Francisco Bay Area
Skills & more
+4 more
Enterprise SoftwareStrategic PlanningTeam LeadershipManagementLanguages English · German
- Making Corporate Boards More Effective — Harvard Business School
From Helen's professional profile.
Deals · 2
Cognito Therapeutics GroupBoard seat
via FoundersX Ventures · filed Apr 2025 · $196.3M raise
Cognito TherapeuticsBoard seat
via FoundersX Ventures · filed Jul 2024 · $60M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
1910 GeneticsAlineaArintraCognito TXJeevesJericho SecurityKapitalKernal BioLinvest21.aiMeru HealthNitraSalt SecuritySolve Intelligencespace-xUniversal Quantum
Sources: SEC Form D filings · the firm's website.
Colleagues at FoundersX Ventures
Network2
Investors connected to Helen in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Helen Liang?
- Helen Liang founded FoundersX Ventures in 2016 with backing from a founders circle connected to Stanford, and brings more than 10 years of product experience in high-tech industries. She leads the firm's investing in enterprise AI, fintech, digital health, and biotech. She holds a PhD from the University of Wisconsin-Madison, completed the Harvard HBS PE/VC program (Class of 2022), and is a guest lecturer at Stanford.
- Where does Helen Liang work?
- Helen Liang is Founder & Managing Partner of FS2 and Founder / Managing Partner at FoundersX Ventures and Board director at Cognito Therapeutics Group and Board director at Cognito Therapeutics.
- What does Helen Liang invest in?
- Helen Liang invests in AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Fintech.
- What companies did Helen Liang found?
- Helen Liang founded FS2.
- What boards does Helen Liang sit on?
- Helen Liang holds tracked board seats at Cognito Therapeutics, Cognito Therapeutics Group.
- What companies has Helen Liang invested in?
- Investments tracked here include 1910 Genetics, Alinea, Arintra, Cognito TX, Jeeves, Jericho Security, Kapital, Kernal Bio, Linvest21.ai, Meru Health, Nitra, Salt Security, and 3 more.
- Where did Helen Liang go to school?
- Helen Liang studied at Harvard Business School (Corporate Board Executive Program); Stanford University Graduate School of Business (Executive Program, Leadership Development); Harvard Business School (Executive Program, Building a Legacy: Family Office Wealth Management).
Founder mafias
Harvard Business School mafia885
Also came through, then founded or led a company.
+ 878 more
Stanford University Graduate School of Business mafia740
Also came through, then founded or led a company.
+ 733 more
Jeeves mafia10
Also came through, then founded or led a company.
+ 3 more
Nitra mafia4
Also came through, then founded or led a company.
World Labs mafia3
Also came through, then founded or led a company.
Same school
Also attended Harvard Business School2,000
+ 1,994 more
Also attended Stanford University Graduate School of Business1,980
+ 1,974 more
Also attended University of Wisconsin-Madison446
+ 440 more
Shared employers
Also worked at World Labs19
+ 13 more
.jpg)
